NCT00781846View on ClinicalTrials.gov

Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED)

PHASE1CompletedINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions

Solid Tumor

Interventions

DRUG

ridaforolimus

oral tablets, daily for 5 days/week

DRUG

bevacizumab

IV infusion

Sponsors

Collaborators (1)

Ariad Pharmaceuticals

All Listed Sponsors

collaborator

Ariad Pharmaceuticals

INDUSTRY

lead

Merck Sharp & Dohme LLC

INDUSTRY